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NONCOMPRESSIBLE TORSO HEMORRHAGE is the leading cause of potentially preventable death on the battlefield. [1] [2] [3] If not treated promptly, hemorrhage leads to cardiovascular collapse and death. While tourniquets have proven utility in controlling extremity hemorrhage, useful measures to manage shock in the setting of torso injury remain elusive. 4, 5 In 1976, Ledgerwood reported experience with resuscitative thoracotomy with aortic clamping; a maneuver to sustain central pressure and control hemorrhage in the setting of hemoperitoneum and shock. 6 This technique is maximally invasive and survival following its performance is rare. However, with no alternative, resuscitative thoracotomy has been incorporated into civilian and military clinical guidelines. [7] [8] [9] [10] The emergence of endovascular aortic aneurysm repair has resulted in the development of balloons to occlude the aorta and expand endograft components. 11 Aortic balloons have also been shown to be effective in the setting of ruptured aneurysms; a scenario which is comparable to noncompressible torso hemorrhage. In this context balloons are positioned and inflated in the aorta proximal to the rupture to support central pressure and reduce bleeding while resuscitation and anesthesia are initiated. [12] [13] [14] Endovascular aortic balloon occlusion is now preferred as the initial maneuver in this setting and has been credited with a significant improvement in survival. [12] [13] [14] Despite success in the management of aneurysms, the effectiveness of resuscitative aortic balloon occlusion in the setting of noncompressible hemorrhage from trauma is not known. Additionally this endovascular technique has not been compared to thoracotomy and clamping in a large animal model. The objective of this study is to characterize the physiologic impact of aortic balloon occlusion in a model of torso hemorrhage and shock. An additional objective is to compare the effectiveness of this technique to thoracotomy with aortic clamping.
MATERIALS AND METHODS
Study approval and overview. Institutional Animal Care and Use Committee (IACUC) approval was obtained from our institution before the study was undertaken. Procedures were performed at an accredited facility (Lackland Air Force Base, San Antonio, TX) in compliance with IACUC policies and under the supervision of a licensed veterinary staff. Female Yorkshire-Landrace crossbred swine (John Albert, Cibolo, TX) (age range, 5-6 months; weight range, 70-95 kg) were housed at the facility 7 days before the protocol to allow for quarantine and acclimation. Animals were exposed to 4 study phases as follows: baseline (BL), injury, operative, resuscitation (Fig 1) .
The BL phase included induction of anesthesia and placement of vascular access with initial collection of blood for laboratory analysis. The injury phase included simulated prehospital hemorrhage (t minus20 to t 0 minutes) and transport (t 0 to t 10 minutes). For purposes of the study, transport was defined as a ''best case scenario'' time needed to convey a patient to a trauma center. Time zero (t 0 ) was designated as the time after completion of prehospital hemorrhage and the start of a simulated transport. The operative phase comprised maneuvers to manage the vascular injury and initiate resuscitation (t 10 to t 60 minutes). Finally, the resuscitation phase (t 60 to t 360 minutes) included administration of crystalloid and norepinephrine and collection of blood for analyses.
Phases of protocol (Fig 1) . During the injury phase, the animals were hemorrhaged through an iliac artery sheath. The operative phase differed in the sequence of maneuvers used in the approach to the iliac artery sheath. The animals were placed in 3 groups (N = 6/group) to correspond with the 3 types of maneuvers used. The clamp occlusion (CO) group underwent left thoracotomy with aortic clamping followed by laparotomy and iliac artery control. The balloon occlusion (BO) group underwent BO of the thoracic aorta followed by laparotomy and vascular control. The no occlusion (NO) group underwent laparotomy with direct control of the iliac artery without aortic occlusion. Arterial control in the CO and BO groups was performed after aortic occlusion and consisted of exploration of the iliac artery.
After sheath removal, limb reperfusion was established with a temporary vascular shunt (TVS) (Sundt; Integra LifeSciences, Plainsboro, NJ). After TVS placement in the CO and BO groups, aortic occlusion was released. During resuscitation, animals underwent monitoring and laboratory analyses. Crystalloid and norepinephrine were administered to sustain a goal aortic pressure $ 60 mm Hg.
Operative technique. Anesthesia was induced with ketamine and maintained with a range of 2% to 4% isoflurane. Animals underwent similar operative procedures that included exposure of the right carotid artery and jugular vein, as well as exposure of the right brachial artery for monitoring. A carotid flow probe (Transonic Systems, Inc., Ithaca, NY) was placed on the right common carotid artery and central venous access established with a catheter placed in the right jugular vein. Using fluoroscopic guidance, a right brachial arterial line was directed into the aortic arch to enable measurement of central aortic pressure.
Throughout the protocol, the following measurements were monitored: heart rate, temperature, end-tidal carbon dioxide, and pulse oximetry; partial pressure brain tissue oximetry (Licox; Integra NeuroSciences, Plainsboro, NJ) and transcutaneous infrared brain oximetry (Pediatric So-maSensor;Somanetics Corporation, Troy, MI).
During the operative phase, the aorta was clamped through a left thoracotomy in the CO group with elimination of flow confirmed by duplex ultrasonography (z.one ultraÔ System, ZONARE Medical Systems, Inc., Mountainview, CA). In the BO group, aortic occlusion was accomplished with an endovascular balloon (Coda Balloon; Cook Medical Inc, Bloomington, IN) in the thoracic aorta that was inflated distal to the left subclavian artery. Using fluoroscopic guidance, the balloon was positioned into the thoracic aorta through a 14-French (Fr) sheath located in the right iliac artery. Once the balloon was inflated, complete aortic occlusion was confirmed by loss of the transduced arterial wave form from a catheter distal to the balloon placed through a left femoral artery sheath.
In the CO and BO groups, laparotomy with control of the iliac sheath site followed aortic occlusion and occurred prior to placement of the TVS (Table I : Operative phase pre-TVS). After placement of the TVS, extremity reperfusion was established in all groups. In the CO and BO groups, this reperfusion entailed release of the aortic clamp and deflation of the balloon, respectively ( Table I) .
Details of hemorrhage. A standardized method for blood volume estimation and rate of hemorrhage was used. 15 In brief, to gauge hemorrhage rate and volume, the animal's weight was multiplied by an average estimate of total blood volume in adult swine (66 mL/kg), which provided the total blood volume of the animal in milliliters (mL). The target hemorrhage volume was weight-based at 35% of the total blood volume to yield a shock state. A simulated prehospital bleeding time was set at 20 minutes, with half of the target hemorrhage volume removed during the first 7 minutes and the remainder removed during the next 13 minutes. 15 The blood was withdrawn from the iliac artery sheath during the prehospital injury phase and stored for re-transfusion. If the mean arterial pressure decreased below 30 mm Hg, hemorrhage was stopped until the arterial pressure returned to normal and then resumed until completion of the 20-minute simulated prehospital phase. During the operative phase, 20% of the calculated blood volume was returned to the animal as whole blood. To ensure class IV shock, animals were subjected to ongoing hemorrhage (0.15 mL/kg/min) until vascular control was achieved.
Resuscitation. Groups were resuscitated and monitored for 6 hours, with measurements of central perfusion, cerebral perfusion, and endorgan function taken at standardized intervals. Initially, resuscitation included a 20% (calculated total blood volume) aliquot of whole blood. The blood pressure was titrated to a goal mean pressure of 60 mm Hg using 1 liter intravenous fluid bolus. When animals failed a fluid challenge and required additional pharmacologic support to maintain the target blood pressure, norepinephrine (double concentrated at 8 mg/250 mL normal saline) was administered. Norepinephrine doses were titrated to maintain the goal central pressure.
Laboratory and histologic analysis. Laboratory collection occurred at BL and at t 10 , t 60 , t 120 , t 180 , t 240 , t 300 , and t 360 minutes (t 0 starts after prehospital hemorrhage). Monitoring occurred during all phases with additional measures at t 45 pre-TVS (45 minutes posthemorrhage, before TVS placement and reperfusion) and t 45 post-TVS (45 minutes posthemorrhage, after TVS reperfusion). Postmortem studies of tissue and histopathology were used to gauge end-organ damage.
Using the enzyme-linked immunosorbent assay and immunohistochemistry, cardiac ischemia was assessed postmortem by measuring nitrotyrosine content in the ischemic/reperfused cardiac tissue and myeloperoxidase activity. Neurologic injury was measured using Fluoro-Jade B staining and the TUNEL (terminal deoxyribonucleotide transferase-mediated dUTP nick end labeling) assay.
Statistical analysis. Group means of single measures were compared by analysis of variance (ANOVA). Geometric means were compared for measures that were more normally distributed after log-transformation. The overall test of equality of means across groups was tested and considered significant at P < .05 before exploring differences between group pairs. Group comparisons were conducted using a mixed model with a first-order autoregressive covariance structure for repeated measures that treated time as a categorical factor. A sample size of 6 per group provides 80% power to detect a standardized effect size of 0.69 (or approximately 1.4 standard deviation [SD] difference) among means for the physiologic measures, an effect size of 0.75 (1.5 SD difference) for the main effect of time, and an effect size of 1.00 (or approximately 2 SD) for the interaction term when testing with a repeated measures ANOVA at the alpha level of 0.05. Differences in physiologic measures detected at this power level were considered clinically significant for this study. Commercially available software (SAS 9.2; SAS Institute, Inc., Cary, NC) was used for statistical calculations.
RESULTS
Outcomes and perfusion measurements. There was no difference in mortality among the CO, BO, or NO groups (0%, 0%, and 17%, respectively; P = not significant [NS] ). The single fatality in the NO group occurred during the resuscitation phase with no obvious cause of death at necropsy. Total shed blood volume was greatest in the NO group by protocol design, given the increased time of ongoing hemorrhage in this group (CO: 1,998 ± 307 mL; BO: 2,087 ± 105; NO: 2,353 ± 194 mL; P = .03).
All vascular shunts remained patent after placement and throughout the resuscitation phase. A summary of perfusion measures obtained throughout the protocol is demonstrated in Table I . Compared to baseline, central aortic pressure during the operative phase, pre-TVS demonstrated an increase in the CO and BO groups after occlusion of the aorta (CO: 57 ± 4 mm Hg vs 138 ± 12 mm Hg; P < .05; and BO: 59 ± 4 mm Hg vs 146 ± 13 mm Hg; P < .05, respectively), but not in the NO group (NO: 62 ± 4 mm Hg vs 45 ± 4 mm Hg; P = NS) (Fig 2, A) .
Similarly, carotid flow increased during the operative phase, pre-TVS relative to baseline in the CO and BO groups after aortic occlusion, respectively (CO: 1,085 ± 110 mL/min vs 320 ± 29 mL/min; P < .05; and BO: 862 ± 87 mL/min vs 259 ± 24 mL/min; P < .05, respectively), while flow remained unchanged in the NO group (Fig 2, B) . Comparison among groups demonstrated greater central aortic pressures and rates of carotid flow in the CO and BO groups compared to the NO group during the operative phase pre-TVS (P < .05).
All groups demonstrated a decrease in the partial pressure of brain oxygenation (PbtO2) at the end of the injury phase (t 10 ) compared to baseline (CO: 27 ± 42 mm Hg vs 34 ± 25 mm Hg; P < .05; BO: 26 ± 39 vs mm Hg 31 ± 23 mm Hg; P < .05; and NO: 12 ± 18 mm Hg vs 30 ± 22 mm Hg; P < .05).
CO and BO demonstrated an increase in PbtO2 after aortic clamping and aortic BO at the operative phase pre-TVS compared to baseline, respectively (CO: 57 ± 64 mm Hg vs 34 ± 25 mm Hg; P < .05; BO: 40 ± 45 mm Hg vs 31 ± 23 mm Hg; , and partial pressure of brain oxygenation (PbtO2) (C) throughout the protocol phases. *Statistically significant (P < .05) increases in each of these measures compared to baseline (BL) in the clamp occlusion (CO) and balloon occlusion (BO) groups during the operative phase before placement of a temporary vascular shunt (TVS). There was no increase in these measures in the no occlusion (NO) group. P < .05) (Fig 2, C) . In contrast, PbtO2 in the NO group during the operative phase pre-TVS remained lower than baseline (NO: 21 ± 23 mm Hg vs 30 ± 22 mm Hg; P < .05) (Fig 2, C) .
Measures of physiologic derangement. Circulating measures of physiologic derangement are shown in Table II . At the beginning of the resuscitation phase (t 60 ), serum lactate levels were greatest in the CO group (CO: 6.6 ± 1.1 mmol/L vs BO: 4.3 ± 0.7 mmol/L; P < .05; and NO: 2.0 ± 0.3 mmol/L; P < .05) (Fig 3, A) . At this same time point, serum pH was lower and base deficit greater in the CO group compared to the BO and NO groups (serum pH = CO: 7.24 ± 0.03 vs BO: 7.35 ± 0.03; P < .05; and NO: 7.39 ± 0.03; P < .05; base excess = CO: À3.0 ± 1.1 vs BO: 0.7 ± 1.1; P < .05; and NO: 3.9 ± 1.1; P < .05) (Fig 3, B and C) .
Cumulative intravenous fluid and vasopressors requirements during resuscitation are shown in Table III . Of note, there was no difference in hematocrit at the start of the resuscitation (t 60 ) in any of the study groups: CO (30.9% [+3.57% above baseline]); BO (35.5% [+3.97% above mean baseline]); NO (29.6% [À0.18% below mean baseline]). The CO and NO groups required greater cumulative intravenous fluids and cumulative doses of norepinephrine than the BO group to maintain a target central aortic pressure of 60 mm Hg during the resuscitation phase (Fig 4, A and B) .
During the resuscitation phase (t 240 ), the intravenous fluid bolus requirements were greater in the CO and NO groups than the BO group (CO: 3,833 ± 1,835 mL and NO: 2,229 ± 1,643 mL vs BO: 1,667 ± 516 mL, respectively; P < .05). This trend continued throughout the resuscitation phase (t 360 ) (CO: 4,000 ± 1,789 mL and NO: 3,422 ± 1,761 mL vs BO: 2,167 ± 1,643 mL, respectively; P < .05) (Fig 4, A) .
At the end of the resuscitation phase (t 360 ), the CO and NO groups required more norepinephrine than the BO group (CO: 52 ± 28 mcg and NO: 12 ± 14 mcg vs BO 0 ± 0; P < .05) (Fig 4, B) . In addition, of the 6 animals in the CO group, 2 required bolus doses of norepinephrine while on a continuous infusion to avoid cardiopulmonary collapse, whereas no animals in the BO group required vasopressor bolus.
Tissue histology. Brain and myocardial tissue stain demonstrated no differences among the groups, reflecting the limited duration of the protocol (6 hours). No difference in histologic appearance of the thoracic aorta at the occlusion sites between BO and CO groups was observed.
DISCUSSION
This study demonstrates the feasibility of resuscitative aortic BO in a large animal model of end-stage hemorrhagic shock. Endovascular BO resulted in increases in central aortic pressure, carotid flow, and partial oxygenation pressure of the brain that were equal to those increases associated with open clamping of the aorta. In contrast to resuscitative thoracotomy with aortic clamping, findings from this study demonstrate that endovascular BO results in less acidosis and lower resuscitative fluid and pressor requirements. Histologic examination of the aorta revealed no adverse effects associated with BO. Control of bleeding and preservation of central perfusion in the setting of noncompressible hemorrhage remains a dilemma in civilian and military settings. Holcomb et al 1 reviewed information on U.S. Special Operations Forces killed in action during the wars in Iraq and Afghanistan and determined that 50% of potentially survivable deaths were related to uncontrolled hemorrhage. In their conclusion, the authors called for improved methods of intravascular or intracavitary hemostasis that could be rapidly deployed as a resuscitative maneuver.
In a separate study by Kelly et al, 2 uncontrolled hemorrhage again was found to be the leading cause of potentially preventable deaths of U.S. troops killed on the battlefield. Civilian experience with this injury pattern also has been reported in series focused on resuscitative thoracotomy, including a recent study by Seamon et al. 16 Of 50 patients in this study, 8 survived resuscitative thoracotomy. 16 Findings in the model used in this study corroborate other researchers' experiences in the management of ruptured aortic aneurysms. In studies by Mehta et al, 12 Krokos et al, 13 and Mayer et al 14 reporting the use of endovascular techniques to manage ruptured aneurysms, an aortic occlusion balloon is described as an initial, stabilizing maneuver. Notably, BO has been shown as a stabilizing tactic in cases when open endoaneurysmorrhaphy is used as the method of repair. 17, 18 In these instances we advocate hemostatic resuscitation, including permissive hypotension in combination with initiation of central venous access and balanced blood product transfusion.
In most cases, ultrasonographic guidance is used to identify the femoral artery, which is accessed using a modified Seldinger technique with placement of a 5-Fr sheath into the femoral and external iliac artery. Under fluoroscopic guidance, a 0.035-inch guidewire is advanced into the descending thoracic aorta. A larger sheath is then exchanged over this wire after an incision at the skin insertion site. It is through this larger sheath that the compliant aortic occlusion balloon is inserted over the wire to its position in the descending thoracic aorta. After positioning, the balloon is inflated using a mix of saline and contrast to allow visualization of the balloon as the maneuver is accomplished.
Alternatively, a similar sequence of steps can be used to insert the wire and balloon through the brachial artery into the thoracic aorta. Balloon inflation decreases blood loss and supports perfusion while resuscitation is initiated, anesthesia induced, and surgical hemostasis is established. 17, 18 Use of this adjunct in the setting of ruptured aneurysms has contributed to the first decrease in mortality after this lethal disease in approximately 4 decades. In that ruptured aneurysms represent a model of noncompressible torso hemorrhage, it is plausible that this benefit may translate to traumatic forms of hemorrhagic shock as well. [12] [13] [14] Current findings support the results from previous studies performed in models of cardiac arrest and cardiopulmonary resuscitation. Spence et al 19 showed in a canine model that aortic BO during open cardiac massage resulted in a 130% increase in central aortic pressure and 100% improvement in cerebral flow. Sesma and colleagues 20 performed a similar study examining BO during external chest compressions in a porcine model of cardiac arrest. In this latter study, the authors demonstrated increases in coronary (150%) and cerebral (200%) perfusion after inflation of the aortic balloon. Finally, Gedeborg et al 21 reported similar effectiveness of BO in a porcine model of ventricular fibrillation.
In one of the few studies examining aortic BO in the setting of hemorrhagic shock, Poli de Figueiredo et al 22 showed its effectiveness with concomitant administration of hypertonic saline in a canine model. This group concluded that the 2 therapies should be considered as complementary measures for the management of end-stage hemorrhagic shock.
Kralovich et al 23 reported a potentially negative impact of aortic occlusion in a porcine model as central hypertension with ventricular strain and impaired function. The conclusions from that publication are relevant to the current study in which central aortic pressures increased to levels well above baseline after inflation of the aortic balloon (Fig 2) . Although this study does not demonstrate any apparent adverse effects on the left ventricles from the clamp or the BO, the potential for negative effects of severe transient central hypertension would be better assessed in a survival model.
In that regard, we recently demonstrated in a model of abdominal hemorrhage that direct transabdominal control of bleeding results in less physiologic derangement than hemorrhage control following transthoracic or transabdominal aortic clamping. 24 In contrast to open aortic clamping, one advantage of resuscitative aortic balloon occlusion is that it can be applied incrementally while ongoing hemostatic resuscitation restores the patient's blood volume. Based on the findings of these two studies, we surmise that, to a point, the body's autoregulatory mechanisms are superior to a mechanical clamp at appropriately distributing the remaining blood volume to vital tissue beds without inducing hemicorporal ischemia. However after some threshold, if central perfusion pressure to the heart and brain are not supported cardiovascular collapse and death will occur.
Despite evidence supporting the use of aortic BO, the technique has not been implemented widely in clinical practice. This lack of use may be related to limitations in current technology, which is designed primarily for the management of aneurysm disease. Most compliant aortic occlusion balloons today expand to a diameter of 42 mm and require sheaths ranging from 12 to 14 Fr. Such dimensions are necessary for treating dilated aortas and the large sheaths necessary for today's devices are easily placed by surgeons with the aid of fluoroscopy in the operating room. Current technology however is not amenable to trauma scenarios which would require rapid, lower profile arterial access in a younger patient population with normal caliber aortas.
Once technology is improved and further experience with this approach is gained, simulation and laboratory training in endovascular balloon aortic occlusion for resuscitation in shock should be incorporated into hands-on courses such as the Advanced Trauma Operative Management (ATOM; http://atomcourse.com/) and the Advanced Surgical Skills for Exposure in Trauma (ASSET; http:// www.facs.org/xtrauma/education/asset.html), which are offered by the American College of Surgeons (Chicago, IL).
Limitations of this technology and approach notwithstanding, the burden of injury from the wars in Iraq and Afghanistan has necessitated a reappraisal of management techniques for hemorrhagic shock. And, like other operative methods that have been transformed as a result of battlefield requirements (eg, tourniquets, topical hemostatic agents, and resuscitation strategies), the technique of resuscitative aortic occlusion also stands to be advanced as a result of recent wartime experience.
The model used in this study has limitations. Foremost, it provides a short reperfusion period without survival that may have shown resolution of the adverse physiologic profile in the CO group and no benefit from BO. The small sample size used in this study also precluded detection of any mortality difference between groups, whereas the survival rates that were greater than expected raises the possibility that the degree of hemorrhage was insufficient. This factor is relevant because resuscitative aortic occlusion is used as a final measure just before or after cardiovascular collapse. Use of a model that has too little hemorrhage and an artificial vascular injury site may not accurately quantify the effect of these maneuvers in an actual clinical scenario.
The artificial injury site (ie, large-caliber sheath) was chosen to control the variable of hemorrhage and allow the study's focus to be on the method of aortic occlusion. Less controlled methods of intraabdominal hemorrhage might have been more realistic but would also be prone to variability, thus limiting the model's ability to describe aortic occlusion methods. Despite limitations this model provides a basis from which to refine the technique of resuscitative aortic BO, including characterization of varied occlusion times and the development of smaller profile, trauma-specific devices.
In conclusion, this study reports results from a novel model of resuscitative BO of the aorta in end-stage hemorrhagic shock. Endovascular BO is feasible and increases central aortic pressure and perfusion to the brain with less physiologic disturbance than resuscitative thoracotomy with aortic clamping. Improvements in technology including development of lower profile, trauma-specific aortic occlusion systems may allow wider application of this adjunct in cases of noncompressible hemorrhage and even cardiac arrest.
